CytoDyn Inc. Quarterly report pursuant to sections 13 or 15(d)

Stock Options and Warrants (Tables)

9 Months Ended

Feb. 28, 2014

The following table represents stock option and warrant activity as of and for the nine months ended February 28, 2014:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options and warrants outstanding – May 31, 2013		18,146,938		$	1.65		1.86	$	140,321
Granted		18,114,156		$	0.74
Exercised		(50,000	)	$	—
Forfeited/expired/cancelled		(4,240,767	)	$	1.53
Options and warrants outstanding – February 28, 2014		31,970,327		$	1.15		3.39	$	2,691,129

Outstanding exercisable – February 28, 2014		30,211,160		$	1.15		3.38	$	2,591,729